维普中文期刊产品整合服务
8篇 您的检索式:作者名="Redfern WS"
    题名 作者 年代 出处 被引量
1Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development显示文摘REDFERN WS CARLSSON L DAVIS AS 2003Cardiovasc Res2003,58,1:1
2Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development 显示文摘Redfern WS Carlsson L Dsvis AS 2003Cardiovasc Res2003,58,1:1
3Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs:evidence for a provisional safety margin in drug development显示文摘Redfern WS Carlsson L Davis AS 2003Cardiovasc Res2003,58,1:1
4Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development 显示文摘Redfern WS Carlsson L Davis AS 2003Cardiovasc Res2003,58,:1
5Relationships between preclinical cardiac electrophysiology,clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisionalsafety margin in drug development显示文摘REDFERN WS CARLSSON L DAVIS AS 2003Cardiovasc Res2003,58,1:1
6Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsades de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development 显示文摘 CARLSSON L DAVIS AS 2003Cardiovasc Res2003,58,1:1
7Relationships between preclinical cardiac electrophysiology,clinical QT interval prolongation and torsade de pointes for a broad range of drugs:evidence for a provisional safety margin in drug development显示文摘REDFERN WS CARLSSON L DAVIS AS 2003Cardiovasc Res2003,58,1:1
8Relationships be- tween preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development 显示文摘Redfern WS Carlsson L Davis AS 2003Cardiovasc Res2003,58,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费